From the laboratory to the market: innovation in COVID-19 diagnosis

A video-interview with the Chief Executive Officer of a company from the CORONADX project discusses about bringing new diagnostic tests to the market

Published on

27 Sep 2022

Category

Press releases

In this interview, we asked Jan Buch Andersen, one of the members of the EU research project CORONADX, to shade lights on the rules and efforts for bringing innovative diagnostics from the laboratory to the patients and society.

He revealed what are the criteria for approving a new test and what does the CE marking means for a test.

Within the CORONADX project, his company, called CORONADX AB, is responsible for obtaining approvals for Emergency Use Authorisation from regulatory bodies in different countries and for aspects connected to the commercialisation and market introduction of the diagnostic systems developed in the project.

Watch the full interview here

Share this news:
Published on

27 Sep 2022

Category

Press releases

Related updates

Results

See all >

Elimination of Carryover Contamination in Real-Time Reverse Transcriptase Loop-Mediated Isothermal Amplification for Rapid Detection of the SARS-CoV-2 Virus in Point-of-Care Testing

Scientific publications — 20 Apr 2022

Loop-mediated isothermal amplification (LAMP) is being used as a robust rapid diagnostic tool to prevent the transmission of infectious diseases. However, carryover contamination of LAMP-amplified products originating from previous tests has been a problem in LAMP-based bio-analytical assays. In this study, we developed a Cod-uracil-DNA-glycosylase real-time reverse transcriptase LAMP assay (Cod-UNG-rRT-LAMP) for the elimination of...